Hernández-Fernández A, Oñate-Sánchez RE,
Cabrerizo-Merino MC, de-Arriba-de-la-Fuente F, Heras-Fernando I, Vicente-García
V. Influence of oral health
on mucositis in patients undergoing hematopoietic progenitor
cell transplantation (HPCT). Med Oral Patol
Oral Cir Bucal. 2012 Jan 1;17
(1):e94-101.
doi:10.4317/medoral.16997
1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics,
2004. CA Cancer J Clin. 2004;54:8-29.
http://dx.doi.org/10.3322/canjclin.54.1.8
2. Gabriel DA, Shea T, Olajida
O, Serody JS, Comeau T. The effect of oral mucositis on morbidity
and mortality in bone marrow transplant. Semin
Oncol. 2003;30:76-83.
http://dx.doi.org/10.1053/j.seminoncol.2003.11.040
PMid:14727245
3. O’Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ. Infections in patients with hematological cancer:
recent developments. Hematology Am Soc Hematol Educ Program. 2003:438-72.
http://dx.doi.org/10.1182/asheducation-2003.1.438
4. Filicko J, Lazarus HM, Flomenberg
N. Mucosal injury in patients undergoing hematopoietic progenitor cell
transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant. 2003;31:1-10.
http://dx.doi.org/10.1038/sj.bmt.1703776
PMid:12621500
5. Wardley AM, Jayson GC, Swindell
R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative
conditioning regimens and haemopoietic progenitor
rescue. Br J Haematol. 2000;110:292-9.
http://dx.doi.org/10.1046/j.1365-2141.2000.02202.x
PMid:10971384
6. Rapoport AP, Miller Watelet
LF, Linder T, Eberly S, Raubertas
RF, Lipp J, et al. Analysis of factors that correlate
with mucositis in recipients of autologous
and allogeneic stem-cell transplants. J Clin Oncol.
1999;17:2446-53.
PMid:10561308
7. Köstler WJ, Hejna M,
Wenzel C, Zielinski CC. Oral mucositis complicating
chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin. 2001;51:290-315.
http://dx.doi.org/10.3322/canjclin.51.5.290
8. Stiff P. Mucositis
associated with stem cell transplantation: current status and innovative ap-proaches to management. Bone Marrow
Transplant. 2001;27 Suppl
2:S3-S11.
http://dx.doi.org/10.1038/sj.bmt.1702863
PMid:11436115
9. Blijlevens NM, Donnelly JP, De Pauw
BE. Mucosal barrier injury: biology, pathology, clinical counterparts and
consequences of intensive treatment for haematological
malignancy: an overview. Bone Marrow Transplant. 2000;25:1269-78.
http://dx.doi.org/10.1038/sj.bmt.1702447
PMid:10871732
10. Sabater Recolons Mdel M, López López J, Rodríguez de Rivera Campillo ME, Chimenos Küstner E, Conde Vidal
JM. Buccodental health and oral mucositis. Clinical study in patients with hematological diseases. Med Oral Patol Oral Cir Bucal. 2006;11:E497-502.
PMid:17072254
11. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis. 2006;12:229-41.
http://dx.doi.org/10.1111/j.1601-0825.2006.01258.x
PMid:16700732
12. Antunes HS, de Azevedo
AM, da Silva Bouzas LF, Adão
CA, Pinheiro CT, Mayhe R,
et al. Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation pa-tients: a randomized trial. Blood.
2007;109:2250-5.
http://dx.doi.org/10.1182/blood-2006-07-035022
PMid:17053058
13. Beaven AW, Shea TC. Palifermin:
a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies. Expert Opin Pharmacother. 2006;7:2287-99.
http://dx.doi.org/10.1517/14656566.7.16.2287
PMid:17059384
14. López-Castaño F, Oñate-Sánchez RE, Roldán-Chicano R, Cabrerizo-Merino MC. Measurement of secondary mucositis
to oncohematologic treatment by means of different
scale. Review. Med
Oral Patol Oral Cir Bucal.
2005;10:412-21.
PMid:16264377
15. Sonis
ST, Fey EG. Oral complications of cancer therapy.
Oncology (Williston Park). 2002;16:680-6.
PMid:12108892
16. Puyalt Casado M, Jiménez Martinez C, Chimenos Küstner E, López López J, Juliá A. A proto-col for the evaluation and
treatment of oral mucositis in patients with
hematological malignancies. Med Oral. 2003;8:10-8.
PMid:12556718
17. Hobdell M, Petersen PE, Clarkson J, Johnson N.
Global goals for oral health 2020. Int Dent J. 2003;53:285-8.
http://dx.doi.org/10.1111/j.1875-595X.2003.tb00761.x
PMid:14560802
18. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral
mucosal changes associated with bone marrow transplantation. Development
of an oral mucositis index. Cancer.
1992;69:2469-77.
http://dx.doi.org/10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W
19. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unan-swered
questions. Oral Oncol. 2003;39:91-100.
http://dx.doi.org/10.1016/S1368-8375(02)00033-7